RNA Outsourcing Resources

  1. LYO Cycle Development Ensures Success For Oncology Drug Scale-Up 5/14/2026

    An optimized lyophilization cycle removes excess moisture during scale‑up by adjusting drying for larger equipment, improving stability, maintaining efficiency, and supporting clinical validation.

  2. Improvement Of Self-Amplifying RNA Quality And Potency With IVT Optimization 2/4/2026

    Explore our study on optimizing In-Vitro Transcription (IVT) conditions for self-amplifying RNAs to achieve high yields, low residual dsRNA, and improved potency, and learn how these advancements can enhance RNA-based therapies.

  3. Navigating The Shift To Modular Digital Asset Architectures 8/13/2026

    Decoupling metadata from core content creates agile workflows, enabling seamless asset reuse across global channels while maintaining technical precision.

  4. Accelerate LNP Manufacturing With Automated Process Development 2/5/2026

    Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.

  5. Screening T7 Polymerases To Optimize xRNA Yield And Quality 10/31/2025

    Discover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.

  6. Strengthening Europe's Advanced Therapy Supply Chain 3/25/2025

    Ensure the seamless development and commercialization of your ATMPs in Europe with integrated supply chain solutions that optimize logistics, biostorage, and regulatory compliance.

  7. How Global Shifts Are Reshaping ATMP Logistics Beyond Borders 12/29/2025

    Global economic shifts, regulatory changes, and evolving trade dynamics are transforming ATMP logistics, demanding resilient strategies to ensure uninterrupted delivery of advanced therapies worldwide.

  8. Reducing Lead Time, Delivering >99.5% OTIF 1/23/2024

    Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.

  9. What Is The Role Of CROs In Drug Development? 5/13/2025

    CROs are not just facilitators but strategic innovators essential for delivering new therapies to patients efficiently and safely.

  10. Expand Trial Footprints Without Expanding Cryopreservation Risk 8/3/2026

    Transitioning from fresh to frozen starting material stabilizes cell therapy inputs, but isolated workflows introduce risk. Integrated logistics safeguard quality as trial footprints expand.